RARE-X, Broad Institute to Advance Rare Disease Research

RARE-X, Broad Institute to Advance Rare Disease Research

295004

RARE-X, Broad Institute to Advance Rare Disease Research

RARE-X, a collaborative platform for patient-controlled data collection, global data sharing and analysis, is partnering with the Broad Institute of MIT and Harvard to advance and support the discovery of new treatments for 9,500 rare diseases, including Lambert-Eaton myasthenic syndrome (LEMS). The collaboration will leverage Broad Institute’s technology to assist in patient data collection and sharing. “Partnering with the Broad Institute is especially valuable to the rare disease community; benefits include leveraging best-in-class technology, aligning…

You must be logged in to read/download the full post.